G
The NHLBI does not intend to award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted. As a result of this Sources Sought notice, the NHLBI may issue a Request for Quote (RFQ).
THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claims against NHLBI shall arise as a result of a response to this Sources Sought notice or the NHLBI's use of such information as either part of our evaluation process or in developing specifications for any subsequent requirement.
The NHLBI is seeking capability statements from all eligible small business concerns [particularly Small Disadvantaged Businesses (SDB), Woman-owned Small Businesses (WOSB), Historically Underutilized Business Zone (HUBZone) Small Businesses, Veteran-Owned Small Businesses (VOSB) and Service-Disabled Veteran-owned Small Businesses (SDVOSB)] under the North American Industry Classification System (NAICS) code 334516 with a size standard 500 employees.
Based on the responses received from this SOURCES SOUGHT announcement, the proposed acquisition may be solicited as a Total Small Business Set-Aside. All eligible small business concerns responding to this Sources Sought Announcement must have the capabilities to provide
services as below.
Background/Tasks:
The NIH Intramural Sequencing Center (NISC) is seeking to purchase a MiSeq System. NISC currently has several Illumina Genome Analyzer (GA) IIx and several HiSeq 2000 Systems which are proven platform for genetic analysis and functional genomics. NISC is a centralized research facility for performing high-throughput, large-scale DNA sequencing and sequence analysis. Overall the MiSeq System will reduce failures and costly repeats by providing a more accurate cell titer of the library sample before it is loaded onto the HiSeq sequencer which is more expensive to run.
This instrument's parallel sequencing technology leverages clonal cluster formation and proprietary reversible terminator chemistry to give it the speed and reduce the cost of large-scale sequencing to generate billions of bases of high-quality DNA sequence per run. The above sequencing technology also provides an easy-to-use protocol that does not require emulsion PCR which allows for a self-contained system that minimizes handling errors and contamination concerns, eliminating the need for robotics or clean rooms. The MiSeq System is an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, primary and secondary analysis.
Equipment:
1. MiSeq System, Catalog Number: SY-410-1001-PRE, Quantity: One (1) Each.
2. Shipping and Handling.
Interested qualified small business organizations should submit a tailored capability statement for this requirement, not to exceed 20 single-sided pages (including all attachments, resumes, charts, etc.) presented in single-space and using a 12-point font size minimum, that clearly details the ability to perform the aspects of the notice described above and in the draft SOW. All proprietary information should be marked as such. Statements should also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferably placed under the eligible small business concern's name and address). Responses will be reviewed only by NIH personnel and will be held in a confidential manner.
All capability Statements sent in response to this SOURCES SOUGHT notice must be submitted electronically (via email) to Dorothy Maxwell, Contract Specialist, at [email protected] in either MS Word or Adobe Portable Document Format (PDF), by August 26, 2011 7:30 AM, EST. All responses must be received by the specified due date and time in order to be considered.